Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 36.77B | 36.61B | 44.55B | 41.71B | 31.52B |
Gross Profit | 2.57B | 1.92B | 4.45B | 4.15B | 1.56B |
EBITDA | -7.05B | 9.29B | 2.02B | 1.82B | -4.45B |
Net Income | -7.74B | 6.61B | -150.00M | 417.00M | -6.45B |
Balance Sheet | |||||
Total Assets | 32.12B | 38.96B | 42.00B | 39.34B | 37.34B |
Cash, Cash Equivalents and Short-Term Investments | 204.00M | 829.00M | 124.00M | 155.00M | 164.00M |
Total Debt | 7.24B | 2.33B | 10.24B | 8.13B | 8.76B |
Total Liabilities | 18.46B | 17.19B | 26.86B | 24.08B | 22.50B |
Stockholders Equity | 13.66B | 21.77B | 15.13B | 15.26B | 14.84B |
Cash Flow | |||||
Free Cash Flow | -5.02B | -3.05B | -1.47B | -161.00M | -222.00M |
Operating Cash Flow | -4.08B | -2.33B | -985.00M | 481.00M | 1.01B |
Investing Cash Flow | -930.00M | 10.58B | -354.00M | -567.00M | 2.41B |
Financing Cash Flow | 4.38B | -8.15B | 1.90B | -676.00M | -2.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥5.41B | 9.08 | 2.53% | -6.55% | 6.55% | ||
72 Outperform | ¥5.00B | 5.97 | ― | -2.76% | -44.71% | ||
69 Neutral | ¥4.29B | 16.44 | 3.35% | -8.45% | -42.89% | ||
65 Neutral | ¥4.71B | 14.52 | 1.97% | -0.82% | -9.80% | ||
65 Neutral | ¥4.78B | 9.46 | 3.61% | -15.00% | 9.27% | ||
61 Neutral | $10.07B | 6.27 | 0.59% | 3.01% | 2.91% | -45.05% | |
45 Neutral | ¥6.48B | ― | 12.44% | 4.33% | -234.35% |